Introducing HFX

HFX is the sum of excellence in four key areas to support you in providing your patients the best care.


Now Available, FDA-Approved, Artificial Intelligence-based HFX iQ™

HFX iQ is a smart pain management system that uses the largest clinical SCS dataset to recommend the starting program most likely to provide pain relief 1 and adjusts therapy based on each patient's responses to maintain optimized relief. 2

Learn more about HFX iQ

Now Available for Non-Surgical
Back Pain Patients

Approved by the FDA with a specific indication for Non-Surgical Back Pain (NSBP) patients.


Long-Term Responder Rates
Now Also Available for Painful Diabetic Neuropathy

Now Also Available for
Painful Diabetic Neuropathy

The only high frequency (10 kHz) SCS system approved by the FDA with a specific indication for painful diabetic neuropathy.


More Innovative Technologies

More Innovative Technologies

A versatile neuromodulation platform designed for enduring patient success.

Learn About Omnia Powered By Hfx Connect

Ongoing Patient Services & Support

End-to-end partnership with you, supporting patient care and optimal outcomes.

Learn About Services & Support

Maximum Versatility With
Advanced Therapies

Offering maximum versatility with multiple mechanisms to meet the diverse needs of your patients.

Learn About Advanced Therapies

Meaningful Evidence To Support Your Practice

Nevro pursues clinical research to better support healthcare providers in treating chronic pain. No other spinal cord stimulation (SCS) technology has this wealth of quality clinical data to back its technology.

View Meaningful Evidence
Neurosurgery Neuromodulation Annals
Anesthesiology Pain Medicine

More of What They Love

At Nevro, our success is measured by our patients satisfaction. 88% percent of patients treated with 10 kHz Therapy are more independent because of their reduced pain.1

  1. Patients used a Senza, Senza II, or Omnia device offering 10 kHz.
  2. Senza HFX iQ uses a fixed set of instructions to provide optimized treatment recommendations that utilize direct patient input from assessments on pain and quality of life measures.